Morgan Stanley upgraded the Healthcare Facilities sector to Attractive from In-Line. The firm believes improving fundamentals and valuations support a compelling buying opportunity long-term. Morgan Stanley raised its price target forTenet (THC) to $59, LifePoint (LPNT) to $81, Community Health (CYH) to $60, and HCA Holdings (HCA) to $96.
Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER - U... To see the rest of the story go to thefly.com. See Story Here
Oppenheimer lowered the firm's price target on Community Health to $4.50 from $5.50 and keeps an Outperform rating on the shares following quarterly results. The firm notes Community Health maintained its 2024 outlook. Overall, at these levels, Oppenheimer continues to see attractive upside for long-term investors.
Reports Q1 revenue $3.14B, consensus $3.09B. On a same-store basis, admissions increased 3.8% and adjusted admissions increased 1.9%, compared to the same period in 2023. The company said, "We were pleased with our first quarter performance compared to both prior year and prior quarter. Progress was demonstrated on key operational and strategic priorities, and we remain focused on building further momentum as we pursue the opportunities available to us this year"
Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."